The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Tanta University

Status and phase: Enrolling; Phase 3; Phase 2

Conditions: COVID

Treatments: Drug: Ivermectin

Study type: Interventional

Funder types: Other

Identifiers

NCT04351347

ivermecin covid

Details and patient eligibility

About

Efficacy of Ivermectin in larger doses in COVID-19 treatment

Full description

Clinical Study Evaluating the Efficacy of Ivermectin in higher doses in COVID-19 treatment

Enrollment: 300 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with covid 19

Exclusion criteria

• Allergy or side effects to treatment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

300 participants in 2 patient groups

Ivermectin

Experimental group

Description:

Ivermectin alone in larger doses

Treatment:

Drug: Ivermectin

Standard treatment

No Intervention group

Description:

Standard of care treatment